These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 32473607)

  • 21. Liver function test abnormalities at hospital admission are associated with severe course of SARS-CoV-2 infection: a prospective cohort study.
    Weber S; Hellmuth JC; Scherer C; Muenchhoff M; Mayerle J; Gerbes AL
    Gut; 2021 Oct; 70(10):1925-1932. PubMed ID: 33514597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mild versus Severe Liver Injury in SARS-CoV-2 Infection.
    Anastasiou OE; Korth J; Herbstreit F; Witzke O; Lange CM
    Dig Dis; 2021; 39(1):52-57. PubMed ID: 32777784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Features of Patients Infected With Coronavirus Disease 2019 With Elevated Liver Biochemistries: A Multicenter, Retrospective Study.
    Fu Y; Zhu R; Bai T; Han P; He Q; Jing M; Xiong X; Zhao X; Quan R; Chen C; Zhang Y; Tao M; Yi J; Tian D; Yan W
    Hepatology; 2021 Apr; 73(4):1509-1520. PubMed ID: 32602604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical features and risk factors of COVID-19-associated liver injury and function: A retrospective analysis of 830 cases.
    Chen F; Chen W; Chen J; Xu D; Xie W; Wang X; Xie Y
    Ann Hepatol; 2021; 21():100267. PubMed ID: 33053426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver function test abnormalities are associated with a poorer prognosis in Covid-19 patients: Results of a French cohort.
    Chaibi S; Boussier J; Hajj WE; Abitbol Y; Taieb S; Horaist C; Jouannaud V; Wang P; Piquet J; Maurer C; Lahmek P; Nahon S
    Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101556. PubMed ID: 33139241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Characteristics and Risk Factors in Coronavirus Disease 2019 Patients with Liver Injury.
    Zhang D; Zhu Z; Bi J; Feng D; Zhang L; Liu H; Gao Y
    Med Sci Monit; 2020 Dec; 26():e928849. PubMed ID: 33339813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of baseline liver biochemical parameters in 324 cases with novel coronavirus pneumonia in Shanghai area].
    Qian ZP; Mei X; Zhang YY; Zou Y; Zhang ZG; Zhu H; Guo HY; Liu Y; Ling Y; Zhang XY; Wang JF; Lu HZ
    Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):229-233. PubMed ID: 32270660
    [No Abstract]   [Full Text] [Related]  

  • 28. Dynamic changes in liver function parameters in patients with coronavirus disease 2019: a multicentre, retrospective study.
    Zeng QL; Yu ZJ; Ji F; Li GM; Zhang GF; Xu JH; Lin WB; Zhang GQ; Li GT; Cui GL; Wang FS
    BMC Infect Dis; 2021 Aug; 21(1):818. PubMed ID: 34399709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.
    Wang Y; Liu S; Liu H; Li W; Lin F; Jiang L; Li X; Xu P; Zhang L; Zhao L; Cao Y; Kang J; Yang J; Li L; Liu X; Li Y; Nie R; Mu J; Lu F; Zhao S; Lu J; Zhao J
    J Hepatol; 2020 Oct; 73(4):807-816. PubMed ID: 32437830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic and gastrointestinal disturbances in Egyptian patients infected with coronavirus disease 2019: A multicentre cohort study.
    Shousha HI; Afify S; Maher R; Asem N; Fouad E; Mostafa EF; Medhat MA; Abdalazeem A; Elmorsy H; Aziz MM; Mohammed RS; Ibrahem M; Elgarem H; Omran D; Hassany M; Elsayed B; Abdelaziz AY; El Kassas M
    World J Gastroenterol; 2021 Oct; 27(40):6951-6966. PubMed ID: 34790017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic Changes in Liver Function Tests and Their Correlation with Illness Severity and Mortality in Patients with COVID-19: A Retrospective Cohort Study.
    Xu W; Huang C; Fei L; Li Q; Chen L
    Clin Interv Aging; 2021; 16():675-685. PubMed ID: 33911856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Features and Liver Injury in Patients with COVID-19 in the Japanese Population.
    Abe K; Yamamoto T; Matsumoto K; Kikuchi K; Miura R; Tachizawa N; Asaoka Y; Takezawa T; Matsunaga N; Obi S; Tanaka A
    Intern Med; 2020; 59(19):2353-2358. PubMed ID: 32999264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of elevated alanine aminotransferase levels in adult participants from a community-based study from northern part of India.
    Aggarwal N; Singh A; Agarwal A; Dwarakanathan V; Verma AK; Amarchand R; Prakash S; Krishnan A; Sreenivas V; Shalimar ; Ahuja V; Makharia GK
    Indian J Gastroenterol; 2020 Dec; 39(6):608-613. PubMed ID: 33098064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Association of COVID-19 With Acute Kidney Injury Independent of Severity of Illness: A Multicenter Cohort Study.
    Moledina DG; Simonov M; Yamamoto Y; Alausa J; Arora T; Biswas A; Cantley LG; Ghazi L; Greenberg JH; Hinchcliff M; Huang C; Mansour SG; Martin M; Peixoto A; Schulz W; Subair L; Testani JM; Ugwuowo U; Young P; Wilson FP
    Am J Kidney Dis; 2021 Apr; 77(4):490-499.e1. PubMed ID: 33422598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histologic evidence of active liver injury in chronic hepatitis B patients with normal range or minimally elevated alanine aminotransferase levels.
    Hu KQ; Schiff ER; Kowdley KV; Min AD; Shiffman ML; Lee WM; Goodman ZD; Dau LO; Peschell KJ; Fagan EA; Flaherty JF
    J Clin Gastroenterol; 2010 Aug; 44(7):510-6. PubMed ID: 20179614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of liver injury in 445 patients with Corona Virus Disease-19-Single-centre experience from southern India.
    Saithanyamurthi HV; Munirathinam M; Ananthavadivelu M
    Indian J Gastroenterol; 2021 Jun; 40(3):303-308. PubMed ID: 33991309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Re-evaluation of serum alanine aminotransferase upper normal limit and its modulating factors in a large-scale population study.
    Kariv R; Leshno M; Beth-Or A; Strul H; Blendis L; Kokia E; Noff D; Zelber-Sagie S; Sheinberg B; Oren R; Halpern Z
    Liver Int; 2006 May; 26(4):445-50. PubMed ID: 16629648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated liver enzymes portends a higher rate of complication and death in SARS-CoV-2.
    Currier EE; Dabaja M; Jafri SM
    World J Hepatol; 2021 Sep; 13(9):1181-1189. PubMed ID: 34630884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.
    Sanai FM; Babatin MA; Bzeizi KI; Alsohaibani F; Al-Hamoudi W; Alsaad KO; Al Mana H; Handoo FA; Al-Ashgar H; Alghamdi H; Ibrahim A; Aljumah A; Alalwan A; Altraif IH; Al-Hussaini H; Myers RP; Abdo AA
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1493-1499.e2. PubMed ID: 23811251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute Kidney Injury and Renal Replacement Therapy in Critically Ill COVID-19 Patients: Risk Factors and Outcomes: A Single-Center Experience in Brazil.
    Doher MP; Torres de Carvalho FR; Scherer PF; Matsui TN; Ammirati AL; Caldin da Silva B; Barbeiro BG; Carneiro FD; Corrêa TD; Ferraz LJR; Dos Santos BFC; Pereira VG; Batista MC; Monte JCM; Santos OFP; Bellomo R; Serpa Neto A; Durão MS
    Blood Purif; 2021; 50(4-5):520-530. PubMed ID: 33341806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.